Monday, June 09, 2014 9:52:45 PM
Hopefully shorts were at least covered on a day like today, else may create some extra downward pressure to leverage back some gains. Could be a little chaotic for the next week as we work to fill either gap: today's big jump or September's big drop...
If FDA approval is received, the company is about 3 quarters behind on one of its studies but probably a couple quarters ahead of where they would have been on other lines of research based on the priority shift...
The largest concern might be the burn rate. CEO says there is enough to get thru to key points in the research to prove the products. $140M is still over $1.40 per share in valuation... But burn rate has been over $50m per year... Well over...
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM